Sustainability Report

Overview

The report presents iX Biopharma's FY2022 sustainability performance across its group entities. Scope 2 greenhouse gas emissions were reported at 714 t CO2-e, while energy consumption was 890,834 kWh. The company reported 19 products registered or listed on the Australian Register of Therapeutic Goods, average training of 56.4 hours per employee, and zero work-related fatalities.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2022
Publication date: 16 September 2022
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services